Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Biocon shares in focus as Viatris-owned Mylan plans stake sale via block deal: Sources
Viatris-owned Mylan is looking to sell part of its 5.64% stake in Biocon through a block deal in the next seven to eight days, according to sources. The size, pricing and buyers are yet to be determined.
True North cashes out $2 billion for investors as PE firms step up exits
This comes on the back of exits for True North from portfolio firms like FedFina, Niva Bupa, Biocon Biologics, Infinity Fincorp Solutions, Zydus Wellness and Home First Finance.
Five Stocks To Buy: Biocon, IndusInd Bank, Angel One And More | July 6, 2026
Five stocks to buy on July 6.
Analysts back buy-on-dips strategy as Nifty targets 24,450–24,800
Indian stock market analysts are optimistic, anticipating the Nifty to continue its upward trend. They suggest buying on dips around the 24,000-24,150 mark, with potential upside targets reaching 24,800. Several stocks, including Container Corporation of India, IndusInd Bank, Biocon, HDFC Asset Management Company, Shriram Finance, and Piramal Pharma, are highlighted as strong buy recommendations with specific price targets and stop-losses.
Stocks to Watch today: HDFC Bank, Biocon, SJVN, Container Corp, Yes Bank
Stocks to Watch today, June 30, 2026: Tech Mahindra, Axis Bank, Godrej Properties, RITES, SIS, Jagsonpal Pharma, and Sterling and Wilson Renewable Energy are top stocks to remain in focus
Dividend Stocks To Watch Next Week: Bajaj Finance, M&M, Tech Mahindra, Welspun Corp, Biocon — Check Amount, Record Date
Dividend Stocks to Watch
Corporate Actions This Week: Bajaj Finance, Biocon, Bharat Forge, M&M To Trade Ex-Dividend | Full List
Corporate actions include dividend payouts and share buyback.
Biocon's Malaysian partner Duopharma Biotech secures insulin tenders worth over MYR 225 million
Biocon said that its long-standing partner Duopharma Biotech has secured multiple insulin contracts from the Ministry of Health (MoH), Malaysia, valued at over MYR 225 million this year.
Biocon secures multiple insulin contracts from Ministry of Health, Malaysia
Biocon announced that its long-standing partner, Duopharma Biotech Berhad (Duopharma Biotech) via its wholly-owned subsidiary Duopharma (M) Sendirian Berhad, has secured multiple insulin contracts from the Ministry of Health (MoH), Malaysia, valued at over MYR 225 million this year.
Biocon shares gain after partner wins insulin contracts worth 225 million Ringgit in Malaysia
Biocon has been working with Duopharma Biotech since 2016 to address Malaysia's growing diabetes burden. The collaboration has supported more than 4.5 lakh patients so far.
Buy or sell: Gift Nifty signals gap-up opening, Vaishali Parekh recommends three stocks to buy today — 23 June 2026
Buy or sell stocks, 23 June 2026: Vaishali Parekh recommends three stocks to buy today — Hindustan Zinc, Biocon, and Adani Green Energy
Laurus Labs, Biocon, Ather Energy, Lenskart among probable MSCI India Standard Index inclusion candidates, says JM Financial
JM Financial anticipates significant shifts in the MSCI India Standard Index. Laurus Labs and Biocon are flagged as high-probability additions from the Small Cap Index, while Ather Energy and SAIL are medium-probability candidates. SBI Card faces a high probability of exclusion. These potential changes could lead to substantial passive fund inflows into India, estimated around $3.2 billion, impacting institutional investors.